Cluster of cases of high-dose rosuvastatin-associated rhabdomyolysis and recent reduction of rosuvastatin dose for Asians in other countries.
作者信息
Tse M L
机构信息
Hong Kong Poison Information Centre, Hospital Authority, Hong Kong SAR, China.
出版信息
Hong Kong Med J. 2023 Oct;29(5):474. doi: 10.12809/hkmj2310943. Epub 2023 Sep 28.
PMID:37766464
Abstract
摘要
相似文献
1
Cluster of cases of high-dose rosuvastatin-associated rhabdomyolysis and recent reduction of rosuvastatin dose for Asians in other countries.高剂量瑞舒伐他汀相关横纹肌溶解症病例群以及其他国家近期针对亚洲人降低瑞舒伐他汀剂量的情况。
Hong Kong Med J. 2023 Oct;29(5):474. doi: 10.12809/hkmj2310943. Epub 2023 Sep 28.
2
Acute kidney injury and rhabdomyolysis due to ticagrelor and rosuvastatin.替格瑞洛和瑞舒伐他汀引起的急性肾损伤和横纹肌溶解症。
Nurse Pract. 2021 Nov 1;46(11):12-16. doi: 10.1097/01.NPR.0000794540.96561.51.
3
Severe rosuvastatin accumulation with rhabdomyolysis due to drug interactions and low cardiac output syndrome.因药物相互作用和低心输出量综合征导致严重的瑞舒伐他汀蓄积并伴有横纹肌溶解。
Br J Clin Pharmacol. 2019 Jul;85(7):1616-1618. doi: 10.1111/bcp.13950. Epub 2019 May 3.
4
Rosuvastatin-induced rhabdomyolysis due to medication errors.因用药错误导致的瑞舒伐他汀引起的横纹肌溶解症。
Ceska Slov Farm. 2020 Spring;69(2):100-102.
5
Rosuvastatin-Induced Rhabdomyolysis - Possible Role of Ticagrelor and Patients' Pharmacogenetic Profile.瑞舒伐他汀诱导的横纹肌溶解症——替格瑞洛的可能作用及患者的药物遗传学特征。
Basic Clin Pharmacol Toxicol. 2018 Oct;123(4):509-518. doi: 10.1111/bcpt.13035. Epub 2018 Jun 29.
6
Rosuvastatin-related rhabdomyolysis causing severe proximal paraparesis and acute kidney injury.瑞舒伐他汀相关的横纹肌溶解症导致严重的近端下肢轻瘫和急性肾损伤。
BMJ Case Rep. 2019 Oct 9;12(10):e229244. doi: 10.1136/bcr-2019-229244.
7
Renal Tubular Toxicity Associated With Rosuvastatin Therapy.与罗苏伐他汀治疗相关的肾小管毒性。
Am J Kidney Dis. 2017 Mar;69(3):473-476. doi: 10.1053/j.ajkd.2016.08.037. Epub 2016 Nov 14.
8
Infection-Induced Rhabdomyolysis in an Elderly Patient on Stable Rosuvastatin Therapy: A Case Report and Review of the Literature.老年患者在接受稳定的瑞舒伐他汀治疗时发生感染性横纹肌溶解症：一例报告及文献综述
Am J Ther. 2022;29(6):e657-e661. doi: 10.1097/MJT.0000000000001325. Epub 2021 Jan 5.
9
Rosuvastatin and Colchicine combined myotoxicity: lessons to be learnt.瑞舒伐他汀与秋水仙碱联合肌毒性：值得吸取的教训。
CEN Case Rep. 2021 Nov;10(4):570-575. doi: 10.1007/s13730-021-00598-7. Epub 2021 May 24.
10
Pharmacogenomics and tailored polypharmacy: an 80-year-old lady with rosuvastatin-associated rhabdomyolysis and maprotiline-related Ogilvie's syndrome
.药物基因组学与个体化联合用药：一位80岁女性患者，患有瑞舒伐他汀相关的横纹肌溶解症和马普替林相关的奥吉尔维综合征
Int J Clin Pharmacol Ther. 2017 May;55(5):442-448. doi: 10.5414/CP202784.
引用本文的文献
1
Rosuvastatin-Based Lipid-Lowering Therapy for the Control of LDL Cholesterol in Patients at High Vascular Risk.基于瑞舒伐他汀的降脂疗法用于控制高血管风险患者的低密度脂蛋白胆固醇
J Clin Med. 2024 Mar 25;13(7):1894. doi: 10.3390/jcm13071894.
Zotero 插件